ASG Eye Hospital invests 2000 cr to expand India’s eye care access

ASG Eye Hospital, India’s leading super specialty eye care chain, announced its long-term strategic roadmap, Vision 2030, aimed at significantly expanding access to high quality ophthalmic care across the country. Supported by marquee investors General Atlantic and Kedaara Capital, the organisation plans to invest Rs 1,500 to Rs 2,000 crore, by 2030.

This investment will be deployed to expand ASG’s national footprint nearly fourfold, building a network of 600 to 700 centres across India and reinforcing its leadership position in the country’s estimated $5.5 billion eye care market. For the past 20 years, ASG has provided high-quality eye care to everyone, regardless of their financial status or awareness, and made world class healthcare treatments available across the country. Having established a considerable presence with 175+ centres in 95+ cities in India, ASG now intends to focus on the under-served fringe areas.

Vision 2030 follows a three pronged growth strategy that combines targeted acquisitions with accelerated organic expansion. ASG plans to pursue 8 to 10 niche practice acquisitions annually, enabling the integration of strong regional clinical capabilities, building on the playbook established through the recent acquisition of Vasan Eye Care. In parallel, the company will establish 5 to 7 new state of the art centres each year, with a focused push into the 100 districts (annually) where demand for quality eye care is rising rapidly and specialist access remains limited.

Dr. Arun Singhvi, Managing Director and CEO, ASG Eye Hospital, noted, “Vision 2030 is fundamentally about market disruption through impact. With over 80% of vision loss in India being preventable, our expansion is a mission to end unnecessary blindness. We are taking world class eye care out of the metropolitan hubs and into the heartland, where the need is more acute. Our significant investment is a declaration that no Indian should lose their sight due to lack of access or financial barriers. Through Public-Private partnerships and pioneering Tele-ophthalmology, we are building the infrastructure necessary to make quality eye care a right, not a privilege, for every citizen.”

The investment programme extends beyond physical expansion and reflects a sustained commitment to clinical excellence and operational scale. By 2026, ASG’s focus will be to deploy funds and workforce to continue research and development into advanced surgical innovation, diagnostics, and clinician training, while ensuring consistent standards of care across its growing network.

Leveraging centralized procurement and economies of scale, ASG also aims to lower the cost of advanced procedures such as LASIK, cataract, and retina surgeries, improving affordability without compromising clinical outcomes.